The latest closing stock price for Enfusion as of April 17, 2025 is 10.76.
An investor who bought $1,000 worth of Enfusion stock at the IPO in 2021 would have $-457 today, roughly 0 times their original investment - a -18.41% compound annual growth rate over 3 years.
The all-time high Enfusion stock closing price was 22.94 on November 12, 2021.
The Enfusion 52-week high stock price is 11.80, which is 9.7% above the current share price.
The Enfusion 52-week low stock price is 7.83, which is 27.2% below the current share price.
The average Enfusion stock price for the last 52 weeks is 9.68.
An investor who bought $1,000 worth of Enfusion stock at the IPO in 2021 would have $-457 today, roughly 0 times their original investment - a -18.41% compound annual growth rate over 3 years.
The all-time high Enfusion stock closing price was 22.94 on November 12, 2021.
The Enfusion 52-week high stock price is 11.80, which is 9.7% above the current share price.
The Enfusion 52-week low stock price is 7.83, which is 27.2% below the current share price.
The average Enfusion stock price for the last 52 weeks is 9.68.